vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and FIDELITY D & D BANCORP INC (FDBC). Click either name above to swap in a different company.

FIDELITY D & D BANCORP INC is the larger business by last-quarter revenue ($24.4M vs $16.0M, roughly 1.5× CVRx, Inc.). FIDELITY D & D BANCORP INC runs the higher net margin — 32.5% vs -74.5%, a 107.0% gap on every dollar of revenue. On growth, FIDELITY D & D BANCORP INC posted the faster year-over-year revenue change (15.0% vs 4.4%). FIDELITY D & D BANCORP INC produced more free cash flow last quarter ($24.8M vs $-9.8M). Over the past eight quarters, CVRx, Inc.'s revenue compounded faster (22.0% CAGR vs 11.8%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Fidelity D & D Bancorp Inc is a US-based regional bank holding company primarily operating in northeastern Pennsylvania. It offers a full range of retail and commercial banking services including deposit accounts, consumer and business loans, mortgage lending, and wealth management solutions, catering to individual consumers, small businesses and local community clients.

CVRX vs FDBC — Head-to-Head

Bigger by revenue
FDBC
FDBC
1.5× larger
FDBC
$24.4M
$16.0M
CVRX
Growing faster (revenue YoY)
FDBC
FDBC
+10.5% gap
FDBC
15.0%
4.4%
CVRX
Higher net margin
FDBC
FDBC
107.0% more per $
FDBC
32.5%
-74.5%
CVRX
More free cash flow
FDBC
FDBC
$34.7M more FCF
FDBC
$24.8M
$-9.8M
CVRX
Faster 2-yr revenue CAGR
CVRX
CVRX
Annualised
CVRX
22.0%
11.8%
FDBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVRX
CVRX
FDBC
FDBC
Revenue
$16.0M
$24.4M
Net Profit
$-11.9M
$7.9M
Gross Margin
86.3%
Operating Margin
-69.8%
37.7%
Net Margin
-74.5%
32.5%
Revenue YoY
4.4%
15.0%
Net Profit YoY
-12.0%
36.1%
EPS (diluted)
$-0.45
$1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
FDBC
FDBC
Q4 25
$16.0M
$24.4M
Q3 25
$14.7M
$23.5M
Q2 25
$13.6M
$23.3M
Q1 25
$12.3M
$22.0M
Q4 24
$15.3M
$21.2M
Q3 24
$13.4M
$20.4M
Q2 24
$11.8M
$19.7M
Q1 24
$10.8M
$19.5M
Net Profit
CVRX
CVRX
FDBC
FDBC
Q4 25
$-11.9M
$7.9M
Q3 25
$-12.9M
$7.3M
Q2 25
$-14.7M
$6.9M
Q1 25
$-13.8M
$6.0M
Q4 24
$-10.7M
$5.8M
Q3 24
$-13.1M
$5.0M
Q2 24
$-14.0M
$4.9M
Q1 24
$-22.2M
$5.1M
Gross Margin
CVRX
CVRX
FDBC
FDBC
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
Operating Margin
CVRX
CVRX
FDBC
FDBC
Q4 25
-69.8%
37.7%
Q3 25
-83.5%
36.5%
Q2 25
-105.8%
35.5%
Q1 25
-108.8%
32.2%
Q4 24
-67.0%
31.4%
Q3 24
-97.3%
28.2%
Q2 24
-118.3%
28.9%
Q1 24
-206.4%
29.5%
Net Margin
CVRX
CVRX
FDBC
FDBC
Q4 25
-74.5%
32.5%
Q3 25
-87.6%
31.2%
Q2 25
-108.4%
29.7%
Q1 25
-111.5%
27.2%
Q4 24
-69.4%
27.5%
Q3 24
-98.0%
24.3%
Q2 24
-118.8%
25.0%
Q1 24
-206.0%
25.9%
EPS (diluted)
CVRX
CVRX
FDBC
FDBC
Q4 25
$-0.45
$1.29
Q3 25
$-0.49
$1.27
Q2 25
$-0.57
$1.27
Q1 25
$-0.53
$1.03
Q4 24
$-0.39
$1.00
Q3 24
$-0.57
$0.86
Q2 24
$-0.65
$0.86
Q1 24
$-1.04
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
FDBC
FDBC
Cash + ST InvestmentsLiquidity on hand
$75.7M
$148.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.3M
$238.9M
Total Assets
$104.8M
$2.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
FDBC
FDBC
Q4 25
$75.7M
$148.1M
Q3 25
$85.1M
$142.2M
Q2 25
$95.0M
$165.5M
Q1 25
$102.7M
$211.2M
Q4 24
$105.9M
$83.4M
Q3 24
$100.2M
$120.2M
Q2 24
$70.4M
$78.1M
Q1 24
$80.1M
$72.7M
Stockholders' Equity
CVRX
CVRX
FDBC
FDBC
Q4 25
$39.3M
$238.9M
Q3 25
$48.1M
$229.2M
Q2 25
$57.9M
$217.9M
Q1 25
$71.1M
$211.7M
Q4 24
$71.1M
$204.0M
Q3 24
$65.2M
$207.3M
Q2 24
$55.2M
$195.7M
Q1 24
$66.3M
$191.6M
Total Assets
CVRX
CVRX
FDBC
FDBC
Q4 25
$104.8M
$2.7B
Q3 25
$111.3M
$2.7B
Q2 25
$119.6M
$2.7B
Q1 25
$129.6M
$2.7B
Q4 24
$133.4M
$2.6B
Q3 24
$127.7M
$2.6B
Q2 24
$96.0M
$2.5B
Q1 24
$106.2M
$2.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
FDBC
FDBC
Operating Cash FlowLast quarter
$-9.8M
$42.4M
Free Cash FlowOCF − Capex
$-9.8M
$24.8M
FCF MarginFCF / Revenue
-61.3%
101.7%
Capex IntensityCapex / Revenue
0.4%
71.9%
Cash ConversionOCF / Net Profit
5.34×
TTM Free Cash FlowTrailing 4 quarters
$-40.8M
$45.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
FDBC
FDBC
Q4 25
$-9.8M
$42.4M
Q3 25
$-9.7M
$8.4M
Q2 25
$-7.9M
$12.6M
Q1 25
$-12.8M
$11.7M
Q4 24
$-8.0M
$29.6M
Q3 24
$-10.4M
$9.1M
Q2 24
$-9.8M
$8.7M
Q1 24
$-10.9M
$5.3M
Free Cash Flow
CVRX
CVRX
FDBC
FDBC
Q4 25
$-9.8M
$24.8M
Q3 25
$-10.0M
$2.2M
Q2 25
$-8.0M
$6.9M
Q1 25
$-12.9M
$11.5M
Q4 24
$-8.1M
$24.9M
Q3 24
$-10.4M
$7.8M
Q2 24
$-10.2M
$7.2M
Q1 24
$-11.8M
$4.0M
FCF Margin
CVRX
CVRX
FDBC
FDBC
Q4 25
-61.3%
101.7%
Q3 25
-68.1%
9.3%
Q2 25
-59.2%
29.6%
Q1 25
-104.3%
52.3%
Q4 24
-52.5%
117.3%
Q3 24
-78.1%
38.1%
Q2 24
-86.3%
36.6%
Q1 24
-109.7%
20.7%
Capex Intensity
CVRX
CVRX
FDBC
FDBC
Q4 25
0.4%
71.9%
Q3 25
2.0%
26.5%
Q2 25
0.8%
24.4%
Q1 25
0.9%
0.8%
Q4 24
0.3%
22.0%
Q3 24
0.3%
6.3%
Q2 24
3.0%
7.5%
Q1 24
8.5%
6.7%
Cash Conversion
CVRX
CVRX
FDBC
FDBC
Q4 25
5.34×
Q3 25
1.15×
Q2 25
1.82×
Q1 25
1.95×
Q4 24
5.07×
Q3 24
1.83×
Q2 24
1.76×
Q1 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

FDBC
FDBC

Segment breakdown not available.

Related Comparisons